Screener
Regenxbio RGNX Total Current Assets
Total Current Assets at other companies
Other financials
Where this comes from
Reported directly by Regenxbio in its filing.
Tagged under the XBRL concept us-gaap:AssetsCurrent.
The source filing: Regenxbio’s 10-Q, filed August 6, 2026.
- Filed
- Aug 6, 2026, 7:15 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-336725
| Line item | June 30, 2026 | December 31, 2025 |
|---|---|---|
| Prepaid expenses | 11,904 | 11,927 |
| Restricted cash | 225 | — |
| Other current assets | 11,757 | 12,905 |
| Total current assets | 236,157 | 281,281 |
| Marketable securities | — | 10,785 |
| Accounts receivable | 435 | 2,312 |
| Property and equipment, net | 98,452 | 104,855 |
| Operating lease right-of-use assets | 43,867 | 47,156 |
Item 1. Financial Statements.
FAQ
- What is Regenxbio's total current assets?
- Regenxbio (RGNX) reported total current assets of $236.16M in Q2 2026.
- How has Regenxbio's total current assets changed year-over-year?
- Regenxbio's total current assets decreased by 36.8% year-over-year, from $373.75M to $236.16M.
- What is the long-term trend for Regenxbio's total current assets?
- Over 5 years (2020 to 2025), Regenxbio's total current assets has grown at a -11.9% compound annual growth rate (CAGR), from $531.2M to $281.28M.
- What does total current assets mean?
- The sum of all assets expected to be converted to cash or consumed within one year — cash, receivables, inventory, and prepaid expenses.
Ask your AI about Regenxbio's total current assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude